Structure |
Chemical Name |
CAS |
MF |
|
Itraconazole iMpurity 4 |
|
|
|
Ozagrel Impurity 2 |
|
|
|
Olaparib Impurity 22 |
|
|
|
Irbesartan Impurity 14 |
133690-91-2 |
C25H28N6O |
|
Febuxostat Impurity 25 |
1643131-89-8 |
C17H20N2O4S |
|
Pregabalin Impurity 3 |
1928754-83-9 |
C12H22O3 |
|
Bosutinib Impurity 6 |
|
|
|
Ticagrelor Impurity 49 |
2376278-80-5 |
|
|
Edoxaban Impurity 14 |
|
|
|
Indacaterol Impurity 3 |
2250243-41-3 |
C26H32N2O3 |
|
Canagliflozin Impurity 11 |
|
|
|
Oseltamivir Impurity 22 |
|
|
|
Riociguat IMpurtiy B |
|
|
|
Silodosin Impurity C |
|
|
|
Dexmedetomidine-025 |
2250242-52-3 |
C20H22N2 |
|
pranoprofen impurity 15 |
|
|
|
Mono-Hydroxy Sugammadex |
2376607-99-5 |
C69H109NaO47S7 |
|
Metronidazole impurity A |
|
|
|
Sulpiride Impurity 6 |
|
|
|
Cefminox Impurity A |
|
|
|
Cefminox Impurity F |
|
|
|
IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE) |
748812-53-5 |
C25H30N6O2 |
|
FENOFIBRATE RELATED COMPOUND C (25 MG) (1-METHYLETHYL 2-[[2-[4-(4-CHLOROBENZOYL)PHENOXY]-2-METHYLPROPANOYL]OXY]-2-METHYLPROPANOATE) |
217636-48-1 |
C24H27ClO6 |
|
(S-(R* S*))-(+)-N-(1-PHENYLETHYL)-1- AZ& |
120570-09-4 |
C15H24Cl2N2 |
|
VERAPAMIL RELATED COMPOUND B (50 MG) (AL-PHA-[2-[[2-(3,4-DIMETHOXYPHENYL)-ETHYL]METHYLA-MINO]ETHYL]-3,4-DIMETHOXY-ALPHA-(1-METHY-LETHYL)-BENZENEACETONITRILE MONOHYDROCHLORIDE) |
1794-55-4 |
C26H37ClN2O4 |
|
N-(5-(Propionyloxy)pentyl Acrylate) rac-trans-Laudanosine Benzenesulfonate |
155913-32-9 |
C38H49NO11S |
|
1,8-ditosyl-1,4,8,11-tetraazacyclotetradecane dihydrochloride |
|
C24H38Cl2N4O4S2 |
|
Mupirocin iMpurity 5 |
|
C26H44O9 |
|
Tolvaptan Impurity 11 |
150683-27-5 |
C25H23ClN2O3 |
|
methyl 2-(4-(2-chloroacetyl)phenyl)-2-methylpropanoate |
1638785-19-9 |
C13H15ClO3 |
|
1155863-81-2 |
1155863-81-2 |
C23H19F2N3O6 |
|
1175018-73-1 |
1175018-73-1 |
C12H14ClN |
|
Clopidogrel Impurity 44 |
|
C15H14ClNO2S |
|
5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,5,6-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate |
949155-13-9 |
C20H22ClNO5 |
|
Nifedipine impurity 06 |
|
C19H22N2O6 |
|
Moxifloxacin Impurity 10 |
|
|
|
Ticagrelor Impurity 11 |
|
|
|
Parecoxib Impurity 18 |
|
|
|
Teneligliptin Impurity 9 DiHCl |
|
|
|
Pramipexole Impurity Z2 |
|
|
|
1-Propanamine, 3-(diphenylphosphinyl)-N,N-dimethyl- |
962-95-8 |
C17H22NOP |
|
Cabozantinib Impurity 50 |
202917-05-3 |
C17H14N2O5 |
|
Landiolol impurity U |
|
|
|
Teneligliptin Impurity 15 |
|
|
|
Nicergoline EP Impurity I |
|
|
|
Carbamic acid, N-[(4-methylphenyl)sulfonyl]- |
107628-27-3 |
C8H9NO4S |
|
9H-Purin-6-amine, 9-(2-chloropropyl)- |
50615-40-2 |
C8H10ClN5 |
|
Hyoscine Butylbromide EP Impurity G |
|
|
|
Cinacalcet Impurity 38 HCl |
938177-81-2 |
C21H24ClN |
|
Norepinephrine Impurity 23 |
1528622-09-4 |
C9H13NO3 |
|
Brexpiprazole Impurity 77 |
1783311-11-4 |
C12H14N2S |
|
(S)-1-(isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol |
114218-35-8 |
C15H26ClNO3 |
|
1-Pentanone, 1-(2-hydroxy-5-methylphenyl)- |
150033-77-5 |
C12H16O2 |
|
PLSQ-001 TM4-QJ |
1227162-74-4 |
C18H24N2O2 |
|
(2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanoic acid |
2101641-92-1 |
C11H17NO4 |
|
2-Pyridineethanamine, N-methyl-N-[2-(2-pyridinyl)ethyl]-, hydrochloride (1:3) |
2095467-43-7 |
C15H20ClN3 |
|
Droxidopa Impurity 4 |
55382-14-4 |
C31H29NO7 |
|
(1r,4r)-4-(5,6-dibromo-2-methylquinazolin-3(4H)-yl)cyclohexan-1-ol |
|
|
|
Dapagliflozin Impurity (MW:423Da) |
|
|
|
Ramipril - Isomer Impurity 1 |
|
|
|
Aripiprazole peroxide degradation Impurity (MW:480Da) |
|
|
|
Fosinopril Sodium Impurity A (Fosinoprilat) |
|
|
|
Dapoxetine Impurity 40 |
|
|
|
Doxofylline Impurity 15 |
|
|
|
Iohexol Impurity 10 |
|
|
|
Benzylpenicillin EP(CP) Impurity F |
|
|
|
Flucloxacillin sodium EP Impurity A |
|
|
|
Nilotinib Impurity 28 |
1807607-72-2 |
C28H20F3N7O3 |
|
Escitalopram Acid Impurity |
1133881-04-5 |
C20H22FNO3 |
|
1,3,6,10,14-Hexadecapentaene, 3,7,11,15-tetramethyl-, (3E,6E,10E)- |
77898-97-6 |
C20H32 |
|
BROMOCRIPTINE IMPURITY A |
|
C32H40BrN5O5 |
|
LORATADINE IMPURITY F |
|
C22H23ClN2O2 |
|
ZIDOVUDINE IMPURITY A |
|
|
|
Propanoic acid, 2-[[(Z)-[1-(2-amino-4-thiazolyl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methyl-, 1-(1,1-dimethylethyl) ester |
330944-50-8 |
C17H25N5O8S2 |
|
Canagliflozin Peroxide Impurity |
2247196-28-5 |
C24H25FO7S |
|
(αR)-α-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-2-naphthalenemethanamine Hydrochloride |
2200269-28-7 |
C22H23ClF3N |
|
Ceftazidime Double Mother Nucleus Impurity |
|
|
|
Cefuroxime Sodium Trans Impurity I,(E)-Cefuroxime Sodium Impurity I |
|
|
|
Hydroxy TorseMide |
99300-68-2 |
C16H20N4O4S |
|
Hydroxy Varenicline N-Trifluoroacetate |
357426-10-9 |
C15H12F3N3O2 |
|
N-ForMyl Valacyclovir |
847670-62-6 |
C14H20N6O5 |
|
2-Fluorobiphenyl-4-carboxylic Acid |
137045-30-8 |
C13H9FO2 |
|
Theophyllidine Hydrochloride |
116131-08-9 |
C6H10ClN4O |
|
1,4'-Dimethyl-2'-propyl-2,5'-bi-1H-benzimidazole |
887583-89-3 |
C19H20N4 |
|
Tetracyclics compound impurities |
|
|
|
Urapidil Impurity |
770-42-3 |
C8H9BrFN.BrH |
|
N'-(1-Methylazepan-4-yl)benzohydrazine |
117078-69-0 |
C14H22ClN3O |
|
3-(3-Chloropropyl)-7,8-dimethoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-2-one |
85175-65-1 |
C15H20ClNO3 |
|
N-DesMethyl TelMisartan |
144701-81-5 |
C32H28N4O2 |
|
N-De[2-(Methylsulfonyl)ethyl] Lapatinib |
697299-82-4 |
C26H20ClFN4O2 |
|
N-[(3,4-DiMethoxy-2-pyridinyl)Methyl] Pantoprazole Sulfide |
957470-58-5 |
C24H24F2N4O5S |
|
3-Oxo Rosuvastatin SodiuM Salt |
1346606-28-7 |
C22H25FN3NaO6S |
|
Famciclovir Related Compound A (20 mg) (2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol hydrochloride) |
246021-75-0 |
C10H16ClN5O2 |
|
Olopatadine USP RC B |
173174-07-7 |
C21H23NO4 |
|
Ramipril Related Compound A (30 mg) ((2S,3aS,6aS)-1-[(S)2-[[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid) |
108313-11-7 |
C22H30N2O5 |
|
4'-(Difluoromethoxy)acetanilide |
22236-11-9 |
C9H9F2NO2 |
|
EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2S,4R)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- |
1255529-28-2 |
C24H30ClN7O4S |
|
N-carbaMoyl-2-Methyl benzene sulfonaMide |
39051-77-9 |
C8H10N2O3S |
|
Capecitabin iMpurity |
71609-08-0 |
C9H12FN3O4 |
|
4-[[(2RS)-2-Hydroxy-3-(isopropylaMino)propyl]oxy]benzaldehydeHydrochloride (4-[(2RS)-2-Hydroxy-3-[(1-Methylethyl)aMino]propoxy]benzaldehydeHydrochloride) |
|
|